MRFF 2024 National Critical Research Infrastructure Program

What is the MRFF 2024 National Critical Research Infrastructure Program?

The MRFF 2024 National Critical Research Infrastructure Grant Opportunity is a funding initiative aimed at supporting organisations and researchers in developing and expanding infrastructure that enables world-class health and medical research. The program focuses on addressing areas of unmet medical need to improve health outcomes for Australians.

Background

This grant is part of the Medical Research Future Fund (MRFF) and the National Critical Research Infrastructure Initiative. It aims to provide essential research infrastructure to tackle complex health challenges. Funding is available across four streams, each designed to foster innovation, collaboration, and advancements in medical research.

Objectives

The program aims to improve health outcomes by:

  • Enhancing Australia’s research infrastructure – Investing in resources that enable cutting-edge research.
  • Addressing areas of unmet medical need – Providing access to quality data, research platforms and health interventions.
  • Encouraging collaboration – Supporting partnerships with industry, government, and the medical sector to translate research into real-world health benefits.

Program Streams

Applicants can apply under one of four streams:

Stream 1 – Innovation Enablers

Supports the development and expansion of research infrastructure to address unmet medical needs, including:

  • Biobanks
  • Tissue repositories
  • Novel research platforms
  • Secure health data environments

Stream 2– Digitisation of Health Care

Focuses on the development and translation of digital health solutions, such as:

  • Digital therapeutics
  • AI-enabled health interventions (e.g., wearables integrated into clinical practice)
  • Clinical applications and software solutions

Stream 3 – Co-investment Partnerships

Encourages co-investment (cash only) with research institutions, state and territory governments, and industry in critical research infrastructure such as:

  • Facilities, personnel, and equipment to support research capacity and capability
  • Platforms, systems, and services that enable Australian research in unmet medical areas
Stream 4 – mRNA Technology Enablers

Supports the enhancement of mRNA technologies, platforms, and equipment to accelerate the development of mRNA-based vaccines and therapeutics in areas of unmet medical need.

Funding

Grants are available as follows:

  • Up to $3 million for Streams 1 and 2
  • Up to $7 million for Stream 3
  • Up to $4 million for Stream 4

Eligibility Criteria

You may be eligible to apply if you:

  • Have an Australian business number (ABN)
  • Are incorporated in Australia
  • Are one of the following entities:
    – A medical research institute
    – A university
    – A corporate Commonwealth entity
    – A corporation (including businesses and not-for-profits)
  • Meet specific project and expenditure criteria
  • For Stream 3, are applying as part of a consortium that meets the co-investment requirements

Timing

Applications close on Monday, 31 March 2025. 

More Information

 

What is the #1 grant for start-ups?

12,000+ companies access the R&D tax incentive per year that yields a CASH REBATE of up to 43.5%.
This might be perfect your start up.
Do you want to know more?

  • What exactly is the R&D Tax Incentive?
  • How can my startup qualify?
  • What defines eligible R&D activities?
  • What expenditure can be claimed?
  • How do I calculate the potential rebate?
  • How can I identify if my product qualiies for R&D?
  • What is the process to apply?
  • How can I best document my R&D?
  • What are common misconceptions about it?
  • How can we help you through this process?

Bulletpoint is a Melbourne-based consultancy specialising in guiding businesses through the complex process of the R&D tax incentive. With a decade of experience under our belt, we’re proud to be led by Australia’s highest-rated R&D tax consultant. We’ve successfully lodged over 500 R&D claims, demonstrating a proven track record.

Government Grant Consultation

Our approach is straightforward and personable, focusing on cutting through the jargon to help businesses truly understand the definition of R&D in government terms. We’re passionate about what we do, and our clients appreciate this, often commenting on the difference our expertise has made to their businesses. They’ve praised us for uncovering grants they wouldn’t have otherwise known about and for making the whole process less stressful for them.

We’re proud to have an average rating of 4.8 stars from over 250 Google reviews. Despite our success, we continue to strive for improvement, learning from every piece of feedback we receive.

At Bulletpoint, we excel in helping businesses navigate the complexities of the R&D tax incentive process, ensuring they reap the benefits they deserve. As experts in our field, we’re well-versed in what works and what doesn’t when it comes to aligning businesses’ perceptions of R&D with the government’s eligibility criteria.

So, if you’re looking for accessible expertise and a proven success rate, you’ll find it with us at Bulletpoint. We’re ready to guide you through the R&D tax incentive process with a blend of professionalism and personality, ensuring your experience with us is not just successful, but enjoyable as well.

 

Scroll to Top